SLC15A4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.448360E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.767900E-02
Normal-vs-Stage2
1.511810E-02
Normal-vs-Stage3
1.041960E-01
Normal-vs-Stage4
5.855000E-01
Stage1-vs-Stage2
7.085000E-01
Stage1-vs-Stage3
6.527600E-01
Stage1-vs-Stage4
1.506420E-01
Stage2-vs-Stage3
3.808200E-01
Stage2-vs-Stage4
9.034300E-02
Stage3-vs-Stage4
1.901840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.660280E-02
Normal-vs-AfricanAmerican
8.426000E-02
Normal-vs-Asian
7.784300E-03
Caucasian-vs-AfricanAmerican
8.356600E-01
Caucasian-vs-Asian
5.626400E-02
AfricanAmerican-vs-Asian
2.946600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.202020E-02
Normal-vs-Female
2.480000E-02
Male-vs-Female
3.509200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.872200E-02
Normal-vs-Age(41-60Yrs)
1.161840E-02
Normal-vs-Age(61-80Yrs)
2.156000E-02
Normal-vs-Age(81-100Yrs)
1.748050E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.200600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.440800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.114200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.411900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.808410E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.718400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.008100E-02
Normal-vs-Daily Drinker
3.175800E-02
Normal-vs-Weekly Drinker
1.264960E-01
Normal-vs-Occasional Drinker
4.088300E-02
Normal-vs-Social Drinker
3.625800E-02
Non Drinker-vs-Daily Drinker
5.444400E-01
Non Drinker-vs-Weekly Drinker
7.161200E-01
Non Drinker-vs-Occasional Drinker
1.537560E-01
Non Drinker-vs-Social Drinker
8.629400E-01
Daily Drinker-vs-Weekly Drinker
9.308200E-01
Daily Drinker-vs-Occasional Drinker
4.006600E-01
Daily Drinker-vs-Social Drinker
7.253600E-01
Weekly Drinker-vs-Occasional Drinker
5.207400E-01
Weekly Drinker-vs-Social Drinker
8.574400E-01
Occasional Drinker-vs-Social Drinker
2.638800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.391600E-02
Normal-vs-Grade 2
9.763100E-03
Normal-vs-Grade 3
1.512300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.119700E-02
Grade 1-vs-Grade 3
2.062600E-01
Grade 1-vs-Grade 4
9.391600E-02
Grade 2-vs-Grade 3
5.836600E-01
Grade 2-vs-Grade 4
9.763100E-03
Grade 3-vs-Grade 4
1.512300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.398400E-02
Normal-vs-NonDiabetic
6.162900E-03
Diabetic-vs-NonDiabetic
9.311200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.158000E-02
Normal-vs-NoPancreatitis
1.501980E-02
Pancreatitis-vs-NoPancreatitis
8.941600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.468300E-02
Normal-vs-N1
1.674070E-02
N0-vs-N1
5.831600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.662300E-02
Normal-vs-TP53-NonMutant
3.748300E-02
TP53-Mutant-vs-TP53-NonMutant
3.618300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
